Zidovudine and Ototoxicity - a phase IV clinical study of FDA data


Ototoxicity is reported only by a few people who take Zidovudine.

The phase IV clinical study analyzes which people take Zidovudine and have Ototoxicity. It is created by eHealthMe based on reports of 9,692 people who have side effects while taking Zidovudine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 16, 2022

9,692 people reported to have side effects when taking Zidovudine.
Among them, 3 people (0.03%) have Ototoxicity.

What is Zidovudine?

Zidovudine has active ingredients of zidovudine. eHealthMe is studying from 9,331 Zidovudine users for its effectiveness, alternative drugs and more.

What is Ototoxicity?

Ototoxicity (damage to the ear) is found to be associated with 598 drugs and 336 conditions by eHealthMe.

Number of Zidovudine and Ototoxicity reports submitted per year:

Could Zidovudine cause Ototoxicity?

Time on Zidovudine when people have Ototoxicity *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ototoxicity when taking Zidovudine *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Ototoxicity when taking Zidovudine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 66.67 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Zidovudine *:

  1. Lamivudine: 2 people, 66.67%
  2. Zerit: 1 person, 33.33%
  3. Viread: 1 person, 33.33%
  4. Azithromycin: 1 person, 33.33%
  5. Copegus: 1 person, 33.33%
  6. Epivir: 1 person, 33.33%
  7. Ethambutol Hydrochloride: 1 person, 33.33%
  8. Fluconazole: 1 person, 33.33%
  9. Ipratropium Bromide: 1 person, 33.33%
  10. Isoniazid: 1 person, 33.33%

Common side effects people have besides Ototoxicity *:

  1. Tinnitus (a ringing in the ears): 2 people, 66.67%
  2. Hypoacusis (loss of hearing): 1 person, 33.33%
  3. Hearing Impaired: 1 person, 33.33%
  4. Dizziness: 1 person, 33.33%
  5. Deafness Neurosensory: 1 person, 33.33%

Common conditions people have *:

  1. Mycobacterium Kansasii Infection (bacterial infection): 1 person, 33.33%
  2. Hiv Infection: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zidovudine and have Ototoxicity?

Check whether Ototoxicity is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ototoxicity and when was it recovered:

Expand to all the drugs that have ingredients of zidovudine:

Alternative drugs to, pros and cons of Zidovudine:

Common Zidovudine side effects:

Browse all side effects of Zidovudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ototoxicity treatments and more:

COVID vaccines that are related to Ototoxicity:

Common drugs associated with Ototoxicity:

All the drugs that are associated with Ototoxicity:

All the conditions that are associated with Ototoxicity:

How the study uses the data?

The study uses data from the FDA. It is based on zidovudine (the active ingredients of Zidovudine) and Zidovudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: